Advertisement: Bradfield Centre mid
RealVNC mid-banner general
Barr Ellison Solicitors – commercial property
ARM Innovation Hub
Advertisement: Mogrify mid banner
Advertisement: Lynch Wood Park
Advertisement: RSM
Advertisement: CBM
Advertisement: Bridge Fibre mid
Advertisement Cambridge China Centre
RealVNC mid banner careers
Advertisement EY mid
Advertisement: Cambridge Network
31 January, 2017 - 10:35 By Kate Sweeney

Surgical robotics business targets 100 strong headcount in 2017

Patrick Pordage of Cambridge Medical Robotics

Cambridge Medical Robotics, which has ambitions to become the technology cluster’s next billion dollar business, plans to double in size to a headcount of 100 by the end of this year.

CMR has shown its determination to grow the brand globally by acquiring top marketer Patrick Pordage from UK-based international technology product innovator Cambridge Consultants.

Pordage’s unveiling comes hot on the heels of CMR unveiling its next-generation Versius universal surgical robotic concept for minimal access surgery.
CMR claims the cost-effective, flexible, modular system enables numerous robotic arms to be used to provide the versatility and dexterity necessary for a whole range of different laparoscopic procedures.

The company secured $20.3 million in a Series A funding round last year and is currently evaluating the ability of its Versius system to perform upper gastrointestinal, gynaecological, colorectal and renal surgery in cadaveric trials.

It says the system has already demonstrated the ability to visualise and access all these parts of the body – and to perform tissue manipulation, suturing, needle driving and electrosurgery. CMR has so far built 20 proprietary robotic arms, built and tested nine different variants of its fully articulated 5mm instruments, and conducted 11 usability studies. To date, the Versius system has been used by 32 surgeons.

CEO Martin Frost said: “Our mission is to make surgical robotics commonplace in every hospital by providing a cost-effective, flexible, next-generation solution capable of carrying out 90 per cent of minimal access procedures.

“I am very pleased to welcome Patrick Pordage to our world-class team. His track record of success in creating a global brand that leads the way in innovation – particularly when it comes to medical technology – will enable us to accelerate our growth and turn our vision into reality.”

Today global annual revenues for robot-assisted minimal access surgery are approximately $4 billion and are anticipated to reach $20 billion by 2025.

The company has grown rapidly since incorporation in 2014 and has its headquarters in Cambridge. Investors include ABB Technology Ventures, LGT Global, Cambridge Innovation Capital and Escala Capital.

Pordage (pictured above) was marketing communications director at Cambridge Consultants and was part of the management team that grew the company – regarded as one of the founding fathers of the Cambridge technology cluster – by more than 500 per cent and established offices on three continents.

Prior to that, his international career included working for global professional services firm KMPG.

“I am delighted to be joining CMR at this exciting time as it transforms itself from an ambitious startup into a global player that is leading the way for the UK when it comes to next-generation surgical robotics,” said Pordage.
 

Newsletter Subscription

Stay informed of the latest news and features